Evaluation of Dapagliflozin Taken Twice-daily

NCT01217892 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: dapagliflozin
DRUG: dapagliflozin
DRUG: dapagliflozin
DRUG: metformin
DRUG: placebo

Sponsor

AstraZeneca

Collaborators

[object Object]